Bharat Biotech's Covaxin will get approval from the World Health Organisation (WHO) this week, according to details derived from the sources reads.
It was in July that the government had informed Parliament, that it has submitted all documents required for Emergency Use Listing (EUL). World Health Organisation usually takes up to six weeks to decide on Emergency Use Listing (EUL) submissions. Earlier, Mariangela Simao, a WHO Assistant Director-General for vaccines, had said that the UN health agency's assessment of the Bharat Biotech vaccine was "quite advanced" and officials hoped for a decision by mid-September. This is a developing story, and it will be updated on getting further details.
Earlier, World Health Organization Chief Scientist Soumya Swaminathan had said that the decision on emergency approval for Covaxin would be made by August. Developed by Bharat Biotech and the ICMR, Covaxin was approved by the Indian drug controller in January, and has been in use since.
Bharat Biotech's joint managing director Suchitra Ella had also the vaccine would move towards emergency use listing. Approval from the WHO is not expected to be a long-drawn process.